Intra-Cellular Therapies Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,407,772	2,528,239	1,418,906	-	-	-
Market Cap Growth	174.08%	78.18%	-	-	-	-
Enterprise Value	6,446,524	2,581,207	1,388,460	-	-	-
Last Close Price	965.00	392.00	220.00	-	-	-
PE Ratio	95.56	3326.89	-	-	-	-
PS Ratio	14.40	7.78	6.80	-	-	-
PB Ratio	30.49	26.06	14.82	-	-	-
P/TBV Ratio	34.26	31.07	15.58	-	-	-
EV/Sales Ratio	14.49	7.94	6.65	-	-	-
EV/EBITDA Ratio	74.71	358.83	-	-	-	-
EV/EBIT Ratio	83.94	695.65	-	-	-	-
Debt / Equity Ratio	0.19	0.64	0.51	-0.44	-0.10	-0.17
Debt / EBITDA Ratio	0.47	4.85	-	-	10.28	-
Asset Turnover	1.72	1.37	1.10	1.54	1.97	-
Quick Ratio	3.58	1.67	2.35	0.30	0.28	0.24
Current Ratio	4.37	2.06	3.05	0.44	0.55	0.34
Return on Equity (ROE)	47.32%	0.79%	-123.06%	-	-	-
Return on Assets (ROA)	18.56%	0.97%	-13.56%	-3.43%	-3.10%	-
Return on Capital (ROIC)	26.27%	1.53%	-41.73%	-	-	-
Return on Capital Employed (ROCE)	27.80%	2.10%	-	-	-	-
Earnings Yield	1.02%	0.03%	-2.51%	-	-	-
FCF Yield	0.06%	-0.65%	-3.76%	-	-	-
Buyback Yield / Dilution	-4.16%	-12.58%	-5629.05%	-	-	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.